165 related articles for article (PubMed ID: 36840340)
21. Validation of limited sampling strategy for the estimation of mycophenolic acid exposure in Chinese adult liver transplant recipients.
Hao C; Erzheng C; Anwei M; Zhicheng Y; Baiyong S; Xiaxing D; Weixia Z; Chenghong P; Hongwei L
Liver Transpl; 2007 Dec; 13(12):1684-93. PubMed ID: 18044788
[TBL] [Abstract][Full Text] [Related]
22. Comparison of P-glycoprotein function in peripheral blood mononuclear cells ex vivo in stable Black and White male and female kidney transplant recipients.
Tornatore KM; Attwood K; Brazeau D; Sprowl J; Chang S; Gundroo A; Minderman H; Venuto RC
Clin Transl Sci; 2023 Feb; 16(2):184-192. PubMed ID: 36352830
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetic role of protein binding of mycophenolic acid and its glucuronide metabolite in renal transplant recipients.
de Winter BC; van Gelder T; Sombogaard F; Shaw LM; van Hest RM; Mathot RA
J Pharmacokinet Pharmacodyn; 2009 Dec; 36(6):541-64. PubMed ID: 19904584
[TBL] [Abstract][Full Text] [Related]
24. Development and validation of limited sampling strategies for the estimation of mycophenolic acid area under the curve in adult kidney and liver transplant recipients receiving concomitant enteric-coated mycophenolate sodium and tacrolimus.
Pawinski T; Luszczynska P; Durlik M; Majchrzak J; Baczkowska T; Chrzanowska M; Sobiak J; Glyda M; Kuriata-Kordek M; Kamińska D; Krajewska M; Klinger M
Ther Drug Monit; 2013 Dec; 35(6):760-9. PubMed ID: 24192641
[TBL] [Abstract][Full Text] [Related]
25. Limited Sampling Strategy for Estimation of Mycophenolic Acid Exposure in Adult Chinese Heart Transplant Recipients.
Xiang H; Zhou H; Zhang J; Sun Y; Wang Y; Han Y; Cai J
Front Pharmacol; 2021; 12():652333. PubMed ID: 33912061
[No Abstract] [Full Text] [Related]
26. Mycophenolic acid pharmacokinetics during maintenance immunosuppression in African American and Caucasian renal transplant recipients.
Tornatore KM; Sudchada P; Dole K; DiFrancesco R; Leca N; Gundroo AC; Danison RT; Attwood K; Wilding GE; Zack J; Forrest A; Venuto RC
J Clin Pharmacol; 2011 Aug; 51(8):1213-22. PubMed ID: 21209244
[TBL] [Abstract][Full Text] [Related]
27. CYP3A5 and UGT1A9 Polymorphisms Influence Immunosuppressive Therapy in Pediatric Kidney Transplant Recipients.
Krall P; Yañez D; Rojo A; Delucchi Á; Córdova M; Morales J; Boza P; de la Rivera A; Espinoza N; Armijo N; Castañeda LE; Farfán MJ; Salas C
Front Pharmacol; 2021; 12():653525. PubMed ID: 33967795
[No Abstract] [Full Text] [Related]
28. The pharmacokinetics and pharmacodynamics of mycophenolate mofetil in younger and elderly renal transplant recipients.
Tang JT; de Winter BC; Hesselink DA; Sombogaard F; Wang LL; van Gelder T
Br J Clin Pharmacol; 2017 Apr; 83(4):812-822. PubMed ID: 27753146
[TBL] [Abstract][Full Text] [Related]
29. Limited sampling models and Bayesian estimation for mycophenolic acid area under the curve prediction in stable renal transplant patients co-medicated with ciclosporin or sirolimus.
Musuamba FT; Rousseau A; Bosmans JL; Senessael JJ; Cumps J; Marquet P; Wallemacq P; Verbeeck RK
Clin Pharmacokinet; 2009; 48(11):745-58. PubMed ID: 19817503
[TBL] [Abstract][Full Text] [Related]
30. Cyclosporine concentration-dependent increase in concentration ratio of mycophenolic acid acyl and phenol glucuronides to mycophenolic acid in stable kidney transplant recipients.
Mino Y; Naito T; Otsuka A; Ushiyama T; Ozono S; Kagawa Y; Kawakami J
Clin Biochem; 2009 May; 42(7-8):595-601. PubMed ID: 19100248
[TBL] [Abstract][Full Text] [Related]
31. The pharmacokinetics of enteric-coated mycophenolate sodium and its gastrointestinal side effects in de novo renal transplant recipients of Hispanic ethnicity.
Shah T; Tellez-Corrales E; Yang JW; Qazi Y; Wang J; Wilson J; Hutchinson I; Min DI
Ther Drug Monit; 2011 Feb; 33(1):45-9. PubMed ID: 21099740
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics Evaluation of Mycophenolic Acid and Its Glucuronide Metabolite in Chinese Renal Transplant Recipients Receiving Enteric-Coated Mycophenolate Sodium and Tacrolimus.
Xu LY; Jiao Z; Liu FY; Qiu XY; Ji L; Zhang M
Ther Drug Monit; 2018 Oct; 40(5):572-580. PubMed ID: 29847459
[TBL] [Abstract][Full Text] [Related]
33. Long-term changes in mycophenolic acid exposure in combination with tacrolimus and corticosteroids are dose dependent and not reflected by trough plasma concentration: a prospective study in 100 de novo renal allograft recipients.
Kuypers DR; Claes K; Evenepoel P; Maes B; Coosemans W; Pirenne J; Vanrenterghem Y
J Clin Pharmacol; 2003 Aug; 43(8):866-80. PubMed ID: 12953344
[TBL] [Abstract][Full Text] [Related]
34. Mycophenolic acid and mycophenolic acid glucuronide pharmacokinetics in pediatric liver transplant recipients: effect of cyclosporine and tacrolimus comedication.
Brown NW; Aw MM; Mieli-Vergani G; Dhawan A; Tredger JM
Ther Drug Monit; 2002 Oct; 24(5):598-606. PubMed ID: 12352931
[TBL] [Abstract][Full Text] [Related]
35. No impact of age on dose-adjusted pharmacokinetics of tacrolimus, mycophenolic acid and prednisolone 1 month after renal transplantation.
Miura M; Satoh S; Kagaya H; Saito M; Inoue T; Tsuchiya N; Suzuki T; Habuchi T
Eur J Clin Pharmacol; 2009 Oct; 65(10):1047-53. PubMed ID: 19730841
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics and protein adduct formation of the pharmacologically active acyl glucuronide metabolite of mycophenolic acid in pediatric renal transplant recipients.
Shipkova M; Armstrong VW; Weber L; Niedmann PD; Wieland E; Haley J; Tönshoff B; Oellerich M;
Ther Drug Monit; 2002 Jun; 24(3):390-9. PubMed ID: 12021631
[TBL] [Abstract][Full Text] [Related]
37. Total and free mycophenolic acid and its 7-O-glucuronide metabolite in Chinese adult renal transplant patients: pharmacokinetics and application of limited sampling strategies.
Jiao Z; Zhong JY; Zhang M; Shi XJ; Yu YQ; Lu WY
Eur J Clin Pharmacol; 2007 Jan; 63(1):27-37. PubMed ID: 17093994
[TBL] [Abstract][Full Text] [Related]
38. An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients.
Sommerer C; Suwelack B; Dragun D; Schenker P; Hauser IA; Witzke O; Hugo C; Kamar N; Merville P; Junge M; Thaiss F; Nashan B;
Kidney Int; 2019 Jul; 96(1):231-244. PubMed ID: 31027892
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of mycophenolic acid in renal transplant patients with delayed graft function.
Shaw LM; Mick R; Nowak I; Korecka M; Brayman KL
J Clin Pharmacol; 1998 Mar; 38(3):268-75. PubMed ID: 9549665
[TBL] [Abstract][Full Text] [Related]
40. Cyclosporine A and tacrolimus combined with enteric-coated mycophenolate sodium influence the plasma mycophenolic acid concentration - a randomised controlled trial in Chinese live related donor kidney transplant recipients.
Huang HF; Yao X; Chen Y; Xie WQ; Shen-Tu JZ; Chen JH
Int J Clin Pract Suppl; 2014 Apr; (181):4-9. PubMed ID: 24673713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
